CSIMarket


Fulgent Genetics Inc   (FLGT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Fulgent Genetics Inc

FLGT's Fundamental analysis








Fulgent Genetics Inc 's sales fell by -20.64 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 3303

Medical Laboratories industry recorded deterioration of revenues by

Fulgent Genetics Inc faced net loss in contrast to the net income a year ago in III. Quarter 2023

More on FLGT's Growth


Fulgent Genetics Inc
realized net loss in trailing twelve months.

Fulgent Genetics Inc realized cash outflow of $ -2.82per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.17.


More on FLGT's Valuation
 
 Total Debt (Millions $) 3
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,004,535
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.33
 Tangible Book Value (Per Share $) 32.50

Fulgent Genetics Inc
realized net loss in trailing twelve months.

Fulgent Genetics Inc realized cash outflow of $ -2.82per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 2.17.

Fulgent Genetics Inc Price to Book Ratio is at 0.49 lower than Indusry Avg. of 421.06. and higher than S&P 500 Avg. of 0.01

More on FLGT's Valuation

  Market Capitalization (Millions $) 619
  Shares Outstanding (Millions) 30
  Employees 284
  Revenues (TTM) (Millions $) 285
  Net Income (TTM) (Millions $) -65
  Cash Flow (TTM) (Millions $) -85
  Capital Exp. (TTM) (Millions $) -24
  Total Debt (Millions $) 3
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,004,535
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.33
  Tangible Book Value (Per Share $) 32.50

  Market Capitalization (Millions $) 619
  Shares Outstanding (Millions) 30
  Employees 284
  Revenues (TTM) (Millions $) 285
  Net Income (TTM) (Millions $) -65
  Cash Flow (TTM) (Millions $) -85
  Capital Exp. (TTM) (Millions $) -24


    FLGT's Profitability Comparisons
Fulgent Genetics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2023 to 0.26 %.







  Ratio
   Capital Ratio (MRQ) 8.95
  Total Debt to Equity (MRQ) 0
  Tangible Leverage Ratio (MRQ) 0.1
  Asset Turnover Ratio (TTM) 0.21
  Inventory Turnover Ratio (TTM) -



Fulgent Genetics Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in III. Quarter 2023 to 0.26 %.



More on FLGT's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com